Cite
MLA Citation
Nicola Gökbuget et al.. “Blinatumomab vs historic standard‐of‐care treatment for minimal residual disease in adults with B‐cell precursor acute lymphoblastic leukaemia.” European journal of haematology, vol. 104, 2020, pp. 299–309. http://access.bl.uk/ark:/81055/vdc_100103167832.0x000033